Eastman Chemical Q2 2026: Revenue Beats, Adjusted EPS Hits $1.97, Cash Flow Outlook Trimmed
EMN sits 25% above its 52-week low of $56.11 on elevated volume (1.8× avg).
Summary
Eastman Chemical reported Q2 2026 revenue of $2.51B (beating the $2.40B consensus) and adjusted EPS of $1.97, up from $1.60 a year ago. Full-year operating cash flow guidance was trimmed to ~$900M from the prior expectation of approaching 2025 levels.
Key Events · Earnings and Guidance · EMN
-
Q2 Revenue and Earnings Beat
Sales revenue rose 10% year over year to $2.513 billion, exceeding the $2.40 billion consensus. Adjusted EPS of $1.97 compared to $1.60 in Q2 2025, driven by higher volume/mix and favorable price-cost.
-
Cash Flow Guidance Trimmed
Full-year 2026 operating cash flow is now expected to approach $900 million, modestly below the prior expectation of approaching 2025 levels, due to inflationary pressure on accounts receivable.
-
Q3 Outlook: EPS to Approach $1.97
Management projects third-quarter adjusted EPS to approach the Q2 level of $1.97, with higher earnings in Advanced Materials and Fibers partially offset by seasonal declines in Additives & Functional Products and Chemical Intermediates.
-
Cost Savings and Capex on Track
The company remains on track to deliver $125 million to $150 million in cost savings, net of inflation, and expects capital expenditures of approximately $400 million for 2026.
Analysis · EMN · Industrial Applications And Services
Eastman Chemical delivered a strong second quarter, with revenue climbing 10% to $2.51 billion and beating the $2.40 billion consensus. Adjusted EPS of $1.97 handily exceeded the year-ago $1.60, driven by volume growth, favorable price-cost, and cost-reduction initiatives. However, the company modestly lowered its full-year operating cash flow expectation to approaching $900 million, citing inflationary pressure on receivables. The results demonstrate operational resilience amid a dynamic macro environment, but the cash flow revision tempers the beat.
How filings like this one have moved
In the 30 days to Oct 3, 2026, 28.9% of the 1668 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.56%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, EMN was trading at $69.89 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $8B. The 52-week trading range was $56.11 to $83.47. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.